Serum IgG to brain microvascular endothelial cells in multiple sclerosis

Journal of the Neurological Sciences

Volumn 143, Issue 1-2, 1996, Pages 107-113

  Trojano, Maria ^a   Defazio, Giovanni ^a   Ricchiuti, Felicia ^a   De Salvia, Roberto ^a   Livrea, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmunity; Blood brain barrier; Endothelial cell culture; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GADOLINIUM; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE SCLEROSIS; RATS; RATS, WISTAR; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 0030296839     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00184-0     Document Type: Article

References (35)

1. Aarli J.A., Aparicio S.R., Lumsden C.E., Tonder O. Binding of normal human Igg to myelin sheats, glia and neurons. Immunology. 28:1975;171-185.
2. Alvord E.C. (1984) Is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis? In Alvord E.C., Kies M.V., Suckling A.J. (Eds), Experimental Allergic Encephalomyelitis: a Useful Model for Multiple Sclerosis. New York, Alan R. Liss: 503-508.
3. Carson M.P., Haudenschild C.C. Microvascular endothelium and pericytes: high yeld, low passage cultures. In Vitro. 22:1986;344-354.
4. Claudio L., Martiney J.A., Brosnan C. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab. Invest. 70:1994;850-861.
5. Confavreux C., Compston D.A.S., Hommes O.R.et al. A european database for multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 55:1992;671-66.
6. Defazio G., Livrea P., Dal Toso R., Leon A. Antineuronal antibody in cranial dystonia. Mov. Disord. 6:1991;183-184.
7. Defazio G., Dal Toso R., Benvegnù D., Minozzi M.C., Cananzi A.R., Leon A. Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture. Brain Res. 633:1994;206-212.
8. Franceschi M., Comola M., Nemni R., Pinto P., Iannaccone S., Smirne S., Canal N. Neuron-binding antibodies in Alzheimer's disease and Down's syndrome. Neurology. 38(1):1988;285.
9. Gaskin F., Kingsley B.S., Fu S.M. Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody-producing cell lines. J. Exp. Med. 165:1987;245-250.
10. Gay D., Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques: an immunocytological study. Brain. 114:1991;557-572.
11. Jaffe E.A. Endothelial cells and the biology of factor VIII. N. Engl. J. Med. 296:1977;377.
12. Hart M.N., Debault L., Sadewasser K.L., Cancilla P.A., Henriquez E.H. Morphologic effects of antibody to mouse brain endothelium in vivo. J. Neuropathol. Exp. Neurol. 40:1981;84-91.
13. Hawkins C.P., Mackenzie F., Tofts P., du Bulay E.P.G.H., McDonald W.I. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain. 118:1991;801-810.
14. Hawkins C.P., Munro P.M.G., Mackenzie F., Kesselring J., Tofts P., du Bulay E.P.G.H., Landon D.N., McDonald W.I. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DPTA and protein markers. Brain. 114:1990;365-378.
15. Hughes C.C.W., Lantos P.L. Brain capillary endothelial cells lack surface IgG Fc receptors. Neurosci. Lett. 68:1986;100-106.
16. Larsen J.P., Kvaale G., Riise T., Nyland H., Aarli J.A. Multiple sclerosis - more than one diseases? Acta Neurol. Scand. 72:1985;145-150.
17. Lightman S.L., Palestine A.G., Rapoport S.I., Rechthand E. Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes. J. Physiol. 389:1987;483-490.
18. Loeffler D.A., Brickman C.M., LeWitt P.A., Bannon M.J., Kukuruga M.A., Cassin B., Kapatos G. Non-specific binding of normal human IgG, including F(ab')2 and Fc fragments, to embryonic rat brain neurons nd human cortex synaptosomes. J. Neuroimmunol. 38:1992;45-52.
19. McLean B.N., Zeman A.Z.J., Barnes D., Thompson E.J. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 56:1993;356-360.
20. Miller D.H., Rudge P., Johnson G., Kendall B.E., Macmanus D.G., Moseley I.F., Barnes D., McDonald W.I. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 111:1988;927-939.
21. Ohguro H., Chiba S., Igarashi Y., Matsumoto H., Akino T., Palczewski K. B-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proc. Natl. Acad. Sci. USA. 90:1993;1123-1128.
22. Olsson T., Baig S., Hojeberg B., Link H. Antimyelin basic protein and antimyelin antibody producing cells in multiple sclerosis. Ann. Neurol. 27:1989;132-136.
23. Poser C.M., Paty D.W., Scheinberg L. New Diagnostic criteria for multiple sclerosis: guidelines for reasearch protocols. Ann. Neurol. 13:1983;227-231.
24. Schumacher G.A., Beebe G., Kibler R.F.et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimantal trials of therapy in multiple sclerosis. Ann. N.Y. Acad. Sci. 122:1965;552-568.
25. Tanaka Y., Tsukada N., Koh Ch-s., Yanagisawa N. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis. J. Neuroimmunol. 17:1987;49-59.
26. Thompson A.J., Kermode A.G., MacManus D.G., Kendall B.E., Kingsley D.P.E., Moseley I.F.et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Br. Med. J. 300:1990;631-634.
27. Thompson A.J., Kermode A.G., MacManus D.G., Kendall B.E., Kingsley D.P.E., Moseley I.F. et al., (1989) Pathogenesis of progressive multiple sclerosis. Lancet, i, 1322-1323.
28. Trojano M., Avolio C., Manzari C., Calò A., De robertis F., Serio G., Livrea P. Multivariate analysis of predictive fators of multiple sclerosis course with a validated method to assess clinical events. J. Neurol. Neurosurg. Psychiat. 58:1995;300-306.
29. Tsukada N., Tanaka Y., Yanagisawa N. Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type 1 associated myelopathy and other demyelinating disorders. J. Neurol. Sci. 90:1989;33-42.
30. Tsukada N., Koh C-S, Yanagisawa N., Okano A., Behan W.M.H., Behan P.O. A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane. Acta Neuropathol. 73:1987;259-266.
31. Tsukada N., Inoue A., Yanagisawa N., Behan W.M.H., Behan P.O. Anti-endothelial cell antibody and immune complexes in the sera of animals with acute experimental allergic encephalomyelitis and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 12:1986;89-97.
32. Ulvestad E., Williams K., Vedeler C., Antel J., Nyland H., Mork S., Matre R. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J. Neurol. Sci. 121:1994;125-131.
33. Unger M., Wettergen A., Clausen J. Characterization of DNA and RNA in circulating immune complexes in multiple sclerosis, amyotrophic lateral sclerosis, and normal controls. Acta Neurol. Scand. 72:1985;392-396.
34. Van Deurs B. Structural aspects of blood-brain barriers with special reference to the permeability of the cerebral endothelium and choroidal epithelium. Int. Rev. Cytol. 65:1980;117-191.
35. Wakefield A.J., More L.J., Difford J., McLaughlin J.E. Immunohistochemical study of vascular injury in acute multiple sclerosis. J. Clin. Pathol. 47:1994;129-133.